Skip to content
THC22%
CBD≤1%
GeneticsHybrid/Indica
CountryPortugalia Portugal
Packaging15g
Synoptis Pharma THC 22%14,40 zł/g – 60,00 zł/g

Pharmacy data may be outdated — last successful update: 9 days ago.

Lineage: Eye Candy × Apples & Bananas

A hybrid with a slight indica lean from Polish company Synoptis Pharma. Initially it provides mental clarity and focus, then induces calming and relaxation, owed to myrcene and linalool. Patients report stimulation and an increase in energy immediately after taking the strain.

What this description is based on: the strain's terpene profile and cannabinoid content, not clinical trials of this product. The terpene profile is approximate. The type of study behind each terpene effect is given in the Terpene Encyclopedia, and clinical publications are collected in Cannabis Research. Where the data comes from

CitrusFruityPepperyPineyHerbal

Patient Experiences

Too little data — only 1 patient review available. Sentiment percentages will appear once at least 5 reviews are collected.

AI summary of publicly available opinions

A patient sharing feedback on the Facade strain focuses primarily on economic aspects and the clinical results achieved. The user report indicates that this herb is characterized by an affordable price point. Furthermore, the patient notes a positive therapeutic effect following the administration of the preparation, which serves as the primary experience documented in the provided feedback regarding this selection.

"dobra cena,efekt pozytywny"

— opinion from a public source (Budcare.pl)

This summary was written automatically by an AI model from 1 opinion in public sources (Budcare.pl). Updated: 20/11/2026. These are individual patient experiences, not clinical trial results — they cannot predict the effect in a particular person. Discuss your choice of strain with a doctor. How summaries are made

Reviews submitted by patients on TerpeneAtlas (0)

Reviews written directly on the website and published after the administrator approves them. They are not part of the AI summary above.

No one has reviewed this strain directly on the website yet. If you use it, describe your experience: your review will appear here once approved and will help other patients.

Be first when Synoptis Pharma releases a new strain

Terpene Profile

  • Limonene: 21%
  • Caryophyllene: 20%
  • Myrcene: 11%
  • Linalool: 10%
  • Humulene: 8%
  • Pinene: 8%
  • Terpinolene: 5%
  • Farnesene: 5%
  • Bisabolol: 3%
  • LimoneneLimonene
  • CaryophylleneCaryophyllene
  • MyrceneMyrcene
  • LinaloolLinalool
  • HumuleneHumulene
  • PinenePinene
  • TerpinoleneTerpinolene
  • FarneseneFarnesene
  • BisabololBisabolol

Terpene release temperatures

Each terpene releases at its boiling point — set your vaporizer to target a specific profile.

Aromatic phase 160–180°CGolden standard 180–205°CFull extraction 205–220°CPyrolysis
PinenPinen8%
155°C
MircenMircen11%
168°C
LimonenLimonen21%
176°C
TerpinolenTerpinolen5%
185°C
LinalolLinalol10%
198°C
FarnezenFarnezen5%
261°C
KariofilenKariofilen20%
263°C
HumulenHumulen8%
276°C
BisabololBisabolol3%
314°C
150°C180°C205°C220°C230°C

Vaporization Temperature Calculator

Optimal range based on the strain's terpene profile and scientific research

Recommended range:185°C – 205°CApproximate range (editorial judgement): monoterpenes degrade from around 200 °C, so a profile dominated by them is better set lower.

The temperature range is an editorial heuristic based on the terpene profile, not a clinical recommendation. Dosage and method of use are determined solely by your treating physician.

Vaporization phases

Four compound-release phases on a single temperature scale

Aromatic phase

160–180°C

Mainly terpenes, low toxicity

Golden standard

180–205°C

THC + CBD + light terpenes

Full extraction

205–220°C

Heavy terpenes (caryophyllene, humulene, nerolidol)

Pyrolysis

220–230°C

Rising risk of breakdown and combustion products — device-dependent

185°C
150°160°180°205°220°230°
150°C185°C · Golden standard230°C
Range most often used in vaporization research: 180–210°C

(approximate scale)

Released abundantly (5)

PinenPinen· 8% · Degr. from 300°CMircenMircen· 11% · Degr. from 200°CLimonenLimonen· 21% · Degr. from 200°CTerpinolenTerpinolen· 5% · Degr. from 200°CLinalolLinalol· 10% · Degr. from 350°C

Partially released (4)

FarnezenFarnezen· 5% · Boils at 261°CKariofilenKariofilen· 20% · Boils at 263°CHumulenHumulen· 8% · Boils at 276°CBisabololBisabolol· 3% · Boils at 314°C

Terpenes release gradually as temperature rises — the evaporation rate depends on the saturated vapor pressure, which increases exponentially with temperature and reaches atmospheric pressure at the boiling point. Below this threshold terpenes evaporate more slowly but still in noticeable amounts, and do not undergo thermal degradation. Each terpene has its own thermal degradation threshold (shown as „degr. from”) — the process is driven by heat energy. In addition to thermal degradation, terpenes also undergo oxidative degradation through contact with oxygen, light and moisture at temperatures below the thermal degradation threshold — which is why it is important to keep the herb out of the sun, in as dark an environment as possible, and to use humidity controllers.

Scientific sources
  • Pomahacova et al. 2009 (PMID 19852551) — cannabinoid-to-byproduct ratio was significantly better at 200 and 230 °C than in smoke, and worst at 170 °C
  • Hazekamp et al. 2006 (PMID 16637053) — evaluation of the Volcano vaporizer with pure THC: vaporization efficiency and reproducibility
  • Lanz et al., Medical Cannabis and Cannabinoids, 2016
  • McGraw et al., USDA Forest Service — thermal degradation of terpenes, 1999
  • Russo, British Journal of Pharmacology, 2011
  • Gieringer et al., MAPS/NORML, 2004

Price history · last 30 days

GdziePoLek price range, not a specific pharmacy offer. Only real observations are saved; a missing observation does not mean unavailable stock.

26.1029.1001.1104.1107.1110.1113.1116.1119.1122.11015304560
  • Minimum
  • Maximum
Chart data (zł/g)
DateMin.Max.
2026-10-2418.5360.00
2026-10-2518.5360.00
2026-10-2618.5360.00
2026-10-2719.4760.00
2026-10-282.0060.00
2026-10-292.0060.00
2026-10-302.0060.00
2026-10-312.0060.00
2026-11-012.0060.00
2026-11-022.0060.00
2026-11-032.0060.00
2026-11-042.8860.00
2026-11-052.8860.00
2026-11-062.8860.00
2026-11-0714.4060.00
2026-11-0814.4060.00
2026-11-0914.4060.00
2026-11-1014.4060.00
2026-11-1114.4060.00
2026-11-1214.4060.00
2026-11-13——
2026-11-14——
2026-11-15——
2026-11-16——
2026-11-17——
2026-11-18——
2026-11-19——
2026-11-20——
2026-11-21——
2026-11-22——

First observation in this period: 2026-10-24. Gaps mean no observation; — means no price.

Book a consultation

Discuss your strain choice with a cannabis medicine doctor

Strains with Similar Terpene Profiles

Balasa (Gorilla Girl)

in pharmacies

COSMA

84% profile match

Hybrid/SativaTHC 20%CBD <1%

Main terpenes

KariofilenCaryophylleneLimonenLimoneneMircenMyrcene
Packaging:10g

Sourdough

in pharmacies

Aurora Deutschland GmbH

82% profile match

IndicaTHC 29%CBD <1%

Main terpenes

LimonenLimoneneKariofilenCaryophylleneMircenMyrcene
Packaging:10g

Blue Cheese

in pharmacies

S-Lab

80% profile match

Hybrid/IndicaTHC 18%CBD ≤1%

Main terpenes

KariofilenCaryophylleneLimonenLimoneneHumulenHumulene
Packaging:15g

Blue Cheese

in pharmacies

Tilray

80% profile match

Hybrid/IndicaTHC 18%CBD <1%

Main terpenes

KariofilenCaryophylleneLimonenLimoneneHumulenHumulene
Packaging:15g

Cataract Kush

in pharmacies

S-Lab

79% profile match

IndicaTHC 18%CBD ≤1%

Main terpenes

MircenMyrceneKariofilenCaryophylleneLimonenLimonene
Packaging:15g

Animal Rntz

in pharmacies

S-Lab

79% profile match

Hybrid/IndicaTHC 18%CBD ≤1%

Main terpenes

KariofilenCaryophylleneLimonenLimoneneLinalolLinalool
Packaging:15g

TerpeneAtlas is run by Ewa Jastrzębska, physician · Indywidualna Praktyka Lekarska Ewa Jastrzębska

TerpeneAtlas.Strain card · for clinicians and patients

Synoptis Pharma

Facade

Synoptis Pharma THC 22%

THC22%
CBD≤1%
GeneticsHybrid/Indica

A hybrid with a slight indica lean from Polish company Synoptis Pharma. Initially it provides mental clarity and focus, then induces calming and relaxation, owed to myrcene and linalool. Patients report stimulation and an increase in energy immediately after taking the strain.

CitrusFruityPepperyPineyHerbal
Limonene
Dominant terpeneLimonene

Product information

Producer
Synoptis Pharma
THC / CBD
22% / ≤1%
Packaging
15g
Product code (EAN/GTIN)
No verified code in the catalogue
GdziePoLek ID (not EAN)
129848
Availability
Unconfirmed
Availability updated
12/11/2026, 21:44:58

Catalogue terpene profile

limonen: 21%, kariofilen: 20%, mircen: 11%, linalol: 10%, humulen: 8%, pinen: 8%, terpinolen: 5%, farnezen: 5%, bisabolol: 3%TerpenesTerpeneAtlas
TerpeneProfile (%)
Limonene21
Caryophyllene20
Myrcene11
Linalool10
Humulene8
Pinene8
Terpinolene5
Farnesene5
Bisabolol3

Profile values are not terpene concentrations in the flower or a batch-specific certificate of analysis (COA). Verify the product, strength, packaging and code in the current registry or product documentation before prescribing. Availability may change.